Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
glioblastoma
Pharma
BMS' Opdivo fails 3rd straight brain cancer test
Bristol-Myers Squibb has once again come up empty-handed in one of the world’s deadliest cancers, glioblastoma.
Carly Helfand
Sep 5, 2019 11:06am
Bayer's Stivarga on the hunt for rare glioblastoma OK
Jun 20, 2019 11:12am
Bristol-Myers' Opdivo fails another brain tumor test
May 9, 2019 10:30am
Antengene, Otsuka and more—FiercePharmaAsia
Jan 4, 2019 10:15am
Seqirus, VBI and Altimmune—News of Note
Aug 22, 2017 4:21pm
Keytruda set for cancer vaccine combo trial in glioblastoma
Jan 17, 2017 2:54pm
